October 04, 2024

Comparing Once-Weekly vs. Daily Insulin Administration for T2D

Can once-weekly insulin efsitora offer equivalent HbA1c reduction as daily degludec for T2D patients—while reducing severe hypoglycemia to zero?

Conexiant

October 04, 2024

How Does Trisomy 21 Affect Fetal Hematopoiesis?

Fetal hematopoietic stem cells in Down syndrome are 'primed' for differentiation, as revealed by single-cell multi-omics of over 1.1 million cells, potentially explaining early hematological abnormalities.

Conexiant

October 04, 2024

Single and Happy? Thank Your Friends

Study reveals 37.9% of single emerging adults are relatively happy, challenging stereotypes and highlighting the crucial role of friendship satisfaction in their well-being.

Conexiant

October 04, 2024

Fathers' Mental Health Improves with Group Therapy: Study

A cluster randomized trial found that a group parenting intervention for fathers with postpartum depression led to significant improvements in paternal mental health and child social-emotional development, with 75% of participants attending 10 or more of the 12 sessions.

Conexiant

October 03, 2024

24-Hour Oxygen Therapy Comparable to 15-Hour Regimen

A recent study compared the effects of 24-hour versus 15-hour long-term oxygen therapy in patients with severe hypoxemia, finding no significant advantage of the former over the latter.

Conexiant

October 02, 2024

HDL Cholesterol's Vitamin D Dance: A Gender Twist

New research reveals that men's HDL cholesterol follows an inverted U-shaped relationship with vitamin D levels, while women maintain a consistently positive correlation.

Conexiant

October 02, 2024

MicroRNA Regulation Linked to Aggressive Prostate Cancer in Hypoxic Tumor

Understanding how prostate cancer cells adapt to hypoxia through microRNA regulation may unlock new approaches for fighting aggressive cancer.

Conexiant

October 02, 2024

Mailed Intervention Aids Older Adults in Reducing Sedative Use

A recent study demonstrates the effectiveness of a mailed, self-guided intervention in reducing long-term sedative use among older adults, with nearly 50% of participants achieving reductions in benzodiazepine receptor agonist (BZRA) use. Participants also reported improvements in sleep outcomes and an increased adoption of cognitive behavioral therapy for insomnia (CBTI) techniques.

Conexiant

September 30, 2024

Roflumilast Cream Effective for Atopic Dermatitis in Phase III Trials

Two phase III clinical trials reveal promising results of once-daily roflumilast cream, 0.15%, in improving symptoms of atopic dermatitis within 4 weeks.

Conexiant